Wendell Yang

Wendell Yang

Company: Imgen BioSciences

Job title: President

Seminars:

Enhancing Therapeutic Impact: Integrating Co- Stimulatory Signaling in TCR-T Therapies 4:50 pm

• Explore how combining TCR-T therapy with co-stimulatory signaling approaches enhances T-cell activation and persistence, and efficacy • Discuss the strategic choices in integration of co-stimulatory signaling, such as in the molecular designs of TCR-based • Chimeric Antigen Receptor (TCR-CAR), to fine-tune immune responses, preventing exhaustion and augmenting durable anti-tumor effects in TCR-T clinical strategies…Read more

day: Conference Day One

Enhancing Therapeutic Impact: Integrating Co- Stimulatory Signaling in TCR-T Therapies 3:30 pm

Explore how combining TCR-T therapy with co-stimulatory signaling approaches enhances T-cell activation and persistence, and efficacy Discuss the strategic choices in integration of co-stimulatory signaling, such as in the molecular designs of TCR-based Chimeric Antigen Receptor (TCR-CAR), to fine-tune immune responses, preventing exhaustion and augmenting durable anti-tumor effects in TCR-T clinical strategies Highlight the potential…Read more

day: DAY ONE TRACK 3 A

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.